Outsourcing

Feb 01, 2018
By BioPharm International Editors
Biopharm industry veteran Ralf Otto named to lead development and manufacturing at Rentschler Biopharma.
Jan 26, 2018
By BioPharm International Editors
The company relocated its headquarters to Riverview, Florida.
Jan 26, 2018
By BioPharm International Editors
The contract development and manufacturing organization has invested £30-million (US$42 million) at its Dundalk, Ireland site to offer expanded clinical trial services.
Jan 26, 2018
By BioPharm International Editors
The companies will be integrated to form the newly-branded AGC Biologics, which will specialize in customized contract development and manufacturing organization services for the scale-up and cGMP manufacture of protein-based therapeutics.
Jan 24, 2018
By BioPharm International Editors
KBI Biopharma's acquisition of Elion Labs expands KBI's biophysical and analytical characterization capabilities.
Jan 23, 2018
By BioPharm International Editors
Paragon Bioservices will build a new cGMP facility in Maryland and expand its existing cGMP facility at the University of Maryland's BioPark.
Jan 16, 2018
By BioPharm International Editors
The acquisition strengthens Charles River Laboratories’ capabilities in the oncology and immunology therapeutic areas.
Jan 01, 2018
BioPharm International
The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.
Jan 01, 2018
BioPharm International
Recent investments show expansion activity in cell culture facilities.
Dec 19, 2017
By BioPharm International Editors
The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.
native1_300x100
lorem ipsum